United Therapeutics
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
UTHR Key Statistics
Stock Snapshot
With a market cap of 25.18B, United Therapeutics(UTHR) trades at $591.17. The stock has a price-to-earnings ratio of 22.38.
During the trading session on 2026-11-14, United Therapeutics(UTHR) shares reached a daily high of $598.84 and a low of $587.00. At a current price of $591.17, the stock is +0.7% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 463.51K, compared to an average daily volume of 527.12K.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $614.23 and a low of $455.63.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $614.23 and a low of $455.63.
UTHR News
...
United Therapeutics reported third quarter 2026 sales of US$832.5 million versus US$799.5 million a year earlier, while net income and diluted EPS from continui...
Analyst ratings
82%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.